---
title: "Kesimpta (ofatumumab) in relapsing multiple sclerosis: Storage and supply questions"
description: "Storage and supply questions on Kesimpta (ofatumumab) in relapsing multiple sclerosis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: How supplied and Storage. Questions: What forms does Kesimpta come in (pen and prefilled syringe)? What needle size does the Kesimpta Sensoready Pen use? How should Kesimpta be stored? How long can Kesimpta be kept out of the refrigerator? 4 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/storage-and-supply"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Kesimpta (ofatumumab) in relapsing multiple sclerosis: Storage and supply questions

Manufacturer: Novartis Pharmaceuticals Corporation  
Prescribing information: [Kesimpta](https://www.novartis.com/us-en/sites/novartis_us/files/kesimpta.pdf)

## How supplied

<a id="kesimpta-dosage-forms"></a>

### What forms does Kesimpta come in (pen and prefilled syringe)?

> “KESIMPTA is a clear to slightly opalescent, and colorless to slightly brownish-yellow solution available as follows: 
> • 
> Injection: 20 mg/0.4 mL in a single-dose prefilled Sensoready Pen 
> • 
> Injection: 20 mg/0.4 mL in a single-dose prefilled syringe”

Source: [KESIMPTA: Prescribing information, page 3, captured 2026-11-13](https://www.novartis.com/us-en/sites/novartis_us/files/kesimpta.pdf#page=3)

<a id="kesimpta-needle-gauge"></a>

### What needle size does the Kesimpta Sensoready Pen use?

> “Sensoready Pen comes with a staked needle of 29 gauge.”

Source: [KESIMPTA: Dosing & Administration, captured 2026-11-13](https://www.kesimptahcp.com/dosing-and-administration#:~:text=Sensoready%20Pen%20comes%20with%20a%20staked%20needle%20of%2029%20gauge.)

## Storage

<a id="kesimpta-storage"></a>

### How should Kesimpta be stored?

> “KESIMPTA Sensoready pens and prefilled syringes must be refrigerated at 2ºC to 8ºC (36ºF to 46ºF). Keep the product in 
> the original carton to protect from light until the time of use. Do not freeze. To avoid foaming, do not shake.”

Source: [KESIMPTA: Prescribing information, page 12, captured 2026-11-13](https://www.novartis.com/us-en/sites/novartis_us/files/kesimpta.pdf#page=12)

<a id="kesimpta-room-temperature"></a>

### How long can Kesimpta be kept out of the refrigerator?

> “If necessary, KESIMPTA may be stored for up to 7 days at room temperature, not to exceed 30°C (86°F). Write the date 
> removed from the refrigerator in the space provided on the carton labeling. If stored below 30°C (86°F), unused 
> KESIMPTA may be returned to the refrigerator and must be used within the next 7 days or discarded after 7 days.”

Source: [KESIMPTA: Prescribing information, page 12, captured 2026-11-13](https://www.novartis.com/us-en/sites/novartis_us/files/kesimpta.pdf#page=12)

## Related pages
- [Medical information: Kesimpta (ofatumumab): Relapsing multiple sclerosis](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis)
- [Indication](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/kesimpta--relapsing-multiple-sclerosis/access-and-coverage)
